ESIKA MEN 2 EN 1 ANTIDANDRUFF MULTI-ACTION

Label at a glance#

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

PYRITHIONE ZINC 0.5%

Purpose

OTC - PURPOSE SECTION

Antidandruff

Uses

INDICATIONS & USAGE SECTION

Reduces the symptoms of dandruff

Warnings

WARNINGS SECTION

For external use only

OTC - WHEN USING SECTION

Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

OTC - ASK DOCTOR SECTION

If condition worsens or does not improve after regular use of this product as directed, consult a doctor

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For best results use at least twice a week or as directed by a doctor.

Inactive ingredients

INACTIVE INGREDIENT SECTION

WATER, SODIUM LAURETH SULFATE, COCAMIDE DEA, COCAMIDOPROPYL BETAINE, DIMETHICONOL, HYDROLYZED SOY PROTEIN, SODIUM CHLORIDE, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, GLYCOL DISTEARATE, TRIETHANOLAMINE, GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE, FRAGRANCE, COCO-GLUCOSIDE, HYDROLYZED RICE PROTEIN, TEA-DODECYLBENZENESULFONATE,HYDROLYZED WHEAT PROTEIN, CITRIC ACID, PROPYLENE GLYCOL, TITANIUM DIOXIDE, GLYCERYL OLEATE, GLYCERYL STEARATE, MAGNESIUM NITRATE, ZINC CHLORIDE, BUTYLENE GLYCOL, BAMBUSA ARUNDINACEA LEAF EXTRACT, BLUE 1, PANTHENOL, YELLOW 5, METHYLCHLOROISOTHIAZOLINONE, MAGNESIUM CHLORIDE, PPG-26-BUTETH-26, METHYLISOTHIAZOLINONE, PEG-40 HYDROGENATED CASTOR OIL, MENTHYL PCA, MENTHOL, DIPROPYLENE GLYCOL, APIGENIN, RED 33, OLEANOLIC ACID, BIOTINOYL TRIPEPTIDE-1, HEXYL CINNAMAL, LINALOOL, BUTYLPHENYL METHYLPROPIONAL, CITRONELLOL.

SPL UNCLASSIFIED SECTION

Dist. by Ventura Corp, Ltd., San Juan, Puerto Rico 00926.

PRINCIPAL DISPLAY PANEL - 300 ml Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MEN

2^en
1

antidandruff shampoo

Multi-action

• >maximum brilliance and softness
• >controls symptoms of dandruff
  with pyrithione zinc
• >hair can be combed more easily

ésika

300 ml e (10.1 fl.oz.)

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 43 matching rows.

• ESIKA MEN 2 EN 1 ANTIDANDRUFF MULTI-ACTION
• Pyrithione Zinc
• WATER
• SODIUM LAURETH-3 SULFATE
• COCO DIETHANOLAMIDE
• COCAMIDOPROPYL BETAINE
• HYDROLYZED SOY PROTEIN (ENZYMATIC; 2000 MW)
• SODIUM CHLORIDE
• CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)
• GLYCOL DISTEARATE
• TROLAMINE
• GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE (1.7 SUBSTITUENTS PER SACCHARIDE)
• COCO GLUCOSIDE
• TRIETHANOLAMINE DODECYLBENZENESULFONATE
• HYDROLYZED WHEAT PROTEIN (ENZYMATIC; 3000 MW)
• CITRIC ACID MONOHYDRATE
• PROPYLENE GLYCOL
• TITANIUM DIOXIDE
• GLYCERYL OLEATE
• GLYCERYL MONOSTEARATE
• MAGNESIUM NITRATE
• ZINC CHLORIDE
• BUTYLENE GLYCOL
• BAMBUSA BAMBOS LEAF
• FD&C BLUE NO. 1
• PANTHENOL
• FD&C YELLOW NO. 5
• METHYLCHLOROISOTHIAZOLINONE
• MAGNESIUM CHLORIDE
• PPG-26-BUTETH-26
• METHYLISOTHIAZOLINONE
• POLYOXYL 40 HYDROGENATED CASTOR OIL
• MENTHYL DL-PYRROLIDONECARBOXYLATE
• MENTHOL, UNSPECIFIED FORM
• DIPROPYLENE GLYCOL
• APIGENIN
• D&C RED NO. 33
• OLEANOLIC ACID
• BIOTINOYL TRIPEPTIDE-1
• .ALPHA.-HEXYLCINNAMALDEHYDE

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 42 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.